Companies / SOM

SOMNOMED LIMITED

ASX:SOMHealth Care Equipment & Services
219.8M shares on issueASX (delayed) · as of 28 July 2026$0.47price · delayed$98.9Mmarket cap · indicative
A
Dilution grade

Options/rights overhang 7% of shares

Cash runwayno data — no longer lodges quarterly cash reports (4C/5B)
Share-count growth (24m)1.7%
Raise cadence (24m)0 cash raises
Options & rights overhang6.8% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

SOMNOMED LIMITED's ordinary share count was 220M as of July 2026, up 1.7% since May 2024. The company did not raise capital in the most recent 24-month window. Options and rights on issue could convert into 15M new shares, equal to 6.8% of the current share count, with the nearest expiry in June 2027 and 0% of current shares in the money. The company no longer lodges quarterly cash reports, so no quarterly cash balance or runway figure is disclosed on that basis. No proposed securities issues (Appendix 3B) are currently pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
6.8%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
Cash cover · stale filings

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 219.8M per ASX (delayed) (28 July 2026).
216.9M217.9M219.0MDec 24Sept 25July 26

Cash runway

stale Last quarterly cash report is more than 12 months old (quarter ended 30 June 2025) — runway is not computed from stale filings.
$15.6M available cash reported at 30 June 2025.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2025.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
24 July 20262A · quoted issueSOM : ORDINARY FULLY PAID219.8MAppendix 2A
22 July 20262A · quoted issueSOM : ORDINARY FULLY PAID219.2MAppendix 2A
20 Mar 20263G · unquotedORDINARY FULLY PAID219.1MAppendix 3G
18 Mar 20262A · quoted issueSOM : ORDINARY FULLY PAID219.1MAppendix 2A
9 Mar 20263H · cancellationSOM : ORDINARY FULLY PAID218.4MAppendix 3H
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

6.8%
Total overhang · of current shares
0.0%
In the money · at current price
15.0M
Potential new shares
June 2027
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
23 July 2026Karen BorgOther1.8M575k3Y notice
4 Dec 2025Amrita Singh BlicksteadOther2.4M1.9M3Y notice
4 Dec 2025Andrew PriceOther300k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.